Professor Melissa Penny, PhD, PD

Burgert L, Zaloumis S, Dini S, Marquart L, Cao P, Cherkaoui M, Gobeau N, McCarthy J, Simpson J.A, Möhrle J.J, Penny M.A. Parasite-host dynamics throughout antimalarial drug development stages complicate the translation of parasite clearance. Antimicrob Agents Chemother. 2021;65(4):e01539-20. DOI: 10.1128/AAC.01539-20

Galactionova K, Smith T.A, Penny M.A. Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S. Malar J. 2021;20:439. DOI: 10.1186/s12936-021-03973-y

Reiker T, Golumbeanu M, Shattock A, Burgert L, Smith T.A, Filippi S, Cameron E, Penny M.A. Emulator-based Bayesian optimization for efficient multi-objective calibration of an individual-based model of malaria. Nat Commun. 2021;12:7212. DOI: 10.1038/s41467-021-27486-z

Shattock A.J, Le Rütte E.A, Dünner R.P, Sen S, Kelly S.L, Chitnis N, Penny M.A. Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland. Epidemics. 2021;38:100535. DOI: 10.1016/j.epidem.2021.100535

Stader F, Courlet P, Kinvig H, Penny M.A, Decosterd L.A, Battegay M, Siccardi M, Marzolini C. Clinical data combined with modelling and simulation indicate unchanged drug-drug interaction magnitudes in the elderly. Clin Pharmacol Ther. 2021;109(2):471-484. DOI: 10.1002/cpt.2017

Burgert L, Rottmann M, Wittlin S, Gobeau N, Krause A, Dingemanse J, Möhrle J.J, Penny M.A. Ensemble modeling highlights importance of understanding parasite-host behavior in preclinical antimalarial drug development. Sci Rep. 2020;10:4410. DOI: 10.1038/s41598-020-61304-8

Camponovo F, Campo J.J, Le T.Q, Oberai A, Hung C, Pablo J.V, Teng A.A, Liang X, Sim B.K.L, Jongo S, Abdulla S, Tanner M, Hoffman S.L, Daubenberger C, Penny M. Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults. Elife. 2020;9:e53080. DOI: 10.7554/eLife.53080

Galactionova K, Velarde M, Silumbe K, Miller J, McDonnell A, Aguas R, Smith T.A, Penny M.A. Costing malaria interventions from pilots to elimination programmes. Malar J. 2020;19:332. DOI: 10.1186/s12936-020-03405-3

Penny M.A, Camponovo F, Chitnis N, Smith T.A, Tanner M. Future use-cases of vaccines in malaria control and elimination. Parasite Epidemiol Control. 2020;10:e00145. DOI: 10.1016/j.parepi.2020.e00145